LinkSquares’ Post

Congrats, Sembcorp Industries Ltd and Cheng (Richard) Li of I-Mab Biopharma, for making the shortlist for “General Counsel of the Year” at the 2024 Asia Legal Awards gala earlier this week. In-house counsel are our crucial partners in the client matters that won us “International Law Firm of the Year”. It is only fitting that your vital contributions to our collective achievements are also recognized. #lawyer #legalawards @sidleyaustin #arbitration #legal #LawFirm

Partner Richard Basile will be a featured speaker at the Joint Patent Practice Continuing Legal Education's 39th Annual Seminar on September 7 in New York City. Rich is part of the biotech and pharma session where he will explore the implications of the Mylan Pharm. Inc. v. Merck Sharp & Dohme Corp decision with his co-panelists. Learn more below. #patentlaw #patentlawyer #biotech #murthacullina

The Life Sciences & Pharma IP Litigation 2024 guide has expanded to 18 jurisdictions. The guide covers the latest developments in patent litigation, generic and biosimilar market entry, patent term extensions, available forms of relief, other IP rights, appeal, ADR and settlement/antitrust considerations. We thank the editors Nicola Dagg, Daniel Lim, Jin Ooi and Gabriella Bornstein from Kirkland & Ellis for their contributions. View the guide here: https://lnkd.in/eDDcYENN

🧬 Celebrating Excellence: Ibarra del Paso Gallego Achieves Tier 2 in Life Sciences - The Legal 500 Latin America 2024 Edition! Thrilled to announce that our Life Sciences practice has been ranked in Tier 2 by The Legal 500 in their 2024 Latin America edition. Recognized for our profound specialization and considerable growth in this sector, our eight-strong team delivers comprehensive legal advisory across all life science segments. Under the leadership of Juan M. Alvarez, we’ve expanded our capabilities, seamlessly integrating regulatory, sanitary consulting, and IP-related matters in life sciences. Client Testimonials underscore our commitment: "The team is made up of competent and experienced people, it is a very specialized practice area and not many law firms in Mexico handle this issue. The members of the team are willing to get involved in meetings and negotiations in which the clients participate and this adds value to their service.” From R&B in Pharmaceuticals, Biotechnology, Healthcare, Medical Devices and related technology with Artificial Intelligence, as well as Chemicals to name a few, we are at the forefront of legal innovation, ensuring our clients navigate the intricacies of the life sciences sector with confidence. Noted for our "highly complex level of consulting," we are proud to be a trusted partner to our clients, contributing to their success and legal strategies. Celebrate this achievement with us! #Legal500 #LifeSciences #IbarradelPasoGallego

Seeing Clearly: Article III Standing of IPR Judicial Review | Patently-O: Jordan Duenckel, a law student and patent agent, discusses the Federal Circuit's dismissal of Allgenesis Biotherapeutics Inc.'s appeal in an inter partes review (IPR) due to insufficient evidence of concrete injury, necessary for Article III standing. Allgenesis failed to prove imminent infringement or the preclusive effect of a patent priority date on its own product development, impacting future IPR challenge requirements by drug development firms. - IP topics: Intellectual Property topics! #ip #intellectualproperty #copyright

Upcoming Event: Driving Successful Legal Operations with Strategic Planning and Continuous Improvement. Catch this dynamic panel moderated by Charles Meier, X1 featuring Shannon Bailey, CMA CGM; Christine Kaufmann, Takeda; Jim Michalowicz, TE Connectivity; Suzanne Dinsmore, BioCryst Pharmaceuticals, Inc.; and Jessica McDonald, XPO at the Consero Legal Operations Forum July 21-23! Hear about success stories and critical learning moments in the Legal Ops arena. To learn more, visit the Consero site at: https://lnkd.in/gfM_ed3v Don't miss it! #eDiscovery #legalops #legaltech #ConseroLegalOps #infogov

The Pharma and Biotech Patent Litigation Summit returns to Anantara Grand Hotel for 3 days practical discussion surrounding the leading patent litigation topics in Europe, with a compare and contrast method with jurisdictions further afield. Our internationally recognised summit will provide you with the necessary practical tools to both defend patent litigation challenges for your pharma and biotech product, whilst also maximising your litigation strategy to allow for successful IP protection. With the central case law and regulatory updates, this event is a must-attend for anyone with a focus on the European market and working within life science IP. Find out more by downloading the agenda: https://hubs.ly/Q02b9dvg0 #summit2024 #pharmaandbiotechpatentlitigationsummit #pharmaandbiotechpatentlitigationeurope #conference2024

The Pharma and Biotech Patent Litigation Summit returns to Anantara Grand Hotel for 3 days practical discussion surrounding the leading patent litigation topics in Europe, with a compare and contrast method with jurisdictions further afield. Our internationally recognised summit will provide you with the necessary practical tools to both defend patent litigation challenges for your pharma and biotech product, whilst also maximising your litigation strategy to allow for successful IP protection. With the central case law and regulatory updates, this event is a must-attend for anyone with a focus on the European market and working within life science IP. Find out more by downloading the agenda: https://hubs.ly/Q02b9dvg0 #summit2024 #pharmaandbiotechpatentlitigationsummit #pharmaandbiotechpatentlitigationeurope #conference2024

The Pharma and Biotech Patent Litigation Summit returns to Anantara Grand Hotel for 3 days practical discussion surrounding the leading patent litigation topics in Europe, with a compare and contrast method with jurisdictions further afield. Our internationally recognised summit will provide you with the necessary practical tools to both defend patent litigation challenges for your pharma and biotech product, whilst also maximising your litigation strategy to allow for successful IP protection. With the central case law and regulatory updates, this event is a must-attend for anyone with a focus on the European market and working within life science IP. Find out more by downloading the agenda: https://rfr.bz/l8pcesf #summit2024 #pharmaandbiotechpatentlitigationsummit #pharmaandbiotechpatentlitigationeurope #conference2024

The Pharma and Biotech Patent Litigation Summit returns to Anantara Grand Hotel for 3 days practical discussion surrounding the leading patent litigation topics in Europe, with a compare and contrast method with jurisdictions further afield. Our internationally recognised summit will provide you with the necessary practical tools to both defend patent litigation challenges for your pharma and biotech product, whilst also maximising your litigation strategy to allow for successful IP protection. With the central case law and regulatory updates, this event is a must-attend for anyone with a focus on the European market and working within life science IP. Find out more by downloading the agenda: https://rfr.bz/l8pcesh #summit2024 #pharmaandbiotechpatentlitigationsummit #pharmaandbiotechpatentlitigationeurope #conference2024